SUBSCRIBE
SUBSCRIBE

Zymeworks, Inc.

NEWS
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Eli Lilly Adds $375 Million To Zymeworks Partnership
October 23, 2014
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026
April 22, 2026
 · 
10 min read
Press Releases
Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
April 20, 2026
 · 
11 min read
Press Releases
Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
April 16, 2026
 · 
2 min read
Press Releases
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth
April 9, 2026
 · 
8 min read
Press Releases
Zymeworks Appoints Kristin Stafford as Chief Financial Officer
April 1, 2026
 · 
7 min read
Press Releases
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
March 30, 2026
 · 
7 min read
Press Releases
Zymeworks Announces Participation in Upcoming April 2026 Investor Conferences
March 24, 2026
 · 
2 min read
Press Releases
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
March 18, 2026
 · 
10 min read
Press Releases
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
March 18, 2026
 · 
13 min read
Press Releases
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 2, 2026
 · 
28 min read
Load More